Literature DB >> 17235542

[Remifentanil-propofol versus fentanyl-midazolam combinations for intracranial surgery: influence of anaesthesia technique and intensive sedation on ventilation times and duration of stay in the ICU].

C Bauer1, S Kreuer, R Ketter, U Grundmann, W Wilhelm.   

Abstract

INTRODUCTION: After neurosurgery patients often need to be sedated and ventilated in the intensive care unit (ICU). However, rapid postoperative recovery and neurological examination are particularly important for the early recognition of complications. In this retrospective study two different strategies of anaesthesia technique and ICU sedation (fentanyl-midazolam versus remifentanil-propofol) were compared.
METHODS: Intraoperatively, patients received continuous infusions of either fentanyl (0.2-1.0 mg/h) and midazolam (2-10 mg/h) or remifentanil (0.2-0.5 microg/kg body weight/min) and propofol (3-6 mg/kg body weight/h). After arrival in the ICU fentanyl (0.03-0.2 mg/h) and midazolam (2-12 mg/h) or remifentanil (0.1-0.2 microg/kg body weight/min) and propofol (0.5-3 mg/kg body weight/h) were infused to reach a Ramsay score of 4. The times between termination of infusion and extubation and the length of stay in the ICU were examined.
RESULTS: A total of 60 patients (n=30 each group) undergoing supratentorial brain tumour surgery were enrolled. The groups were comparable for age, weight, ASA status (American Society of Anesthesiologists) and duration of drug administration (remifentanil-propofol 528+/-382 min versus fentanyl-midazolam 548+/-360 min). Extubation times were significantly shorter after remifentanil-propofol (47 min) than after fentanyl-midazolam (481 min), and the length of stay in the ICU was also significantly reduced (1.8 days versus 3.7 days). As a result of prolonged unconsciousness and impaired neurological assessability, a brain CT scan was necessary in 3 patients after fentanyl-midazolam to exclude neurosurgical complications.
CONCLUSION: This retrospective study demonstrates that remifentanil-propofol anaesthesia and ICU sedation are superior to the combination of fentanyl and midazolam in terms of ventilation time and length of ICU stay. Moreover, the use of fentanyl-midazolam may lead to unnecessary CT scans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235542     DOI: 10.1007/s00101-006-1130-4

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  14 in total

Review 1.  A review of the pharmacokinetics and pharmacodynamics of remifentanil.

Authors:  P S Glass; T J Gan; S Howell
Journal:  Anesth Analg       Date:  1999-10       Impact factor: 5.108

2.  Remifentanil in the critically ill.

Authors:  T N Evane; G R Park
Journal:  Anaesthesia       Date:  1997-08       Impact factor: 6.955

3.  Long-term respiratory support and risk of pneumonia in critically ill patients. Intensive Care Unit Group of Infection Control.

Authors:  M Langer; P Mosconi; M Cigada; M Mandelli
Journal:  Am Rev Respir Dis       Date:  1989-08

Review 4.  Sedation in the intensive care unit: a systematic review.

Authors:  M E Ostermann; S P Keenan; R A Seiferling; W J Sibbald
Journal:  JAMA       Date:  2000-03-15       Impact factor: 56.272

5.  A comparison of remifentanil and sufentanil as adjuvants during sevoflurane anesthesia with epidural analgesia for upper abdominal surgery: effects on postoperative recovery and respiratory function.

Authors:  A Casati; A Albertin; G Fanelli; F Deni; M Berti; G Danelli; F Grifoni; G Torri
Journal:  Anesth Analg       Date:  2000-11       Impact factor: 5.108

6.  Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs.

Authors:  R Barrientos-Vega; M Mar Sánchez-Soria; C Morales-García; A Robas-Gómez; R Cuena-Boy; A Ayensa-Rincon
Journal:  Crit Care Med       Date:  1997-01       Impact factor: 7.598

Review 7.  Ventilator-associated pneumonia.

Authors:  Jean Chastre; Jean-Yves Fagon
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

Review 8.  [Remifentanil. An update].

Authors:  W Wilhelm; M Wrobel; S Kreuer; R Larsen
Journal:  Anaesthesist       Date:  2003-06       Impact factor: 1.041

9.  Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: a randomized double blind study.

Authors:  Ashraf A Dahaba; Tanja Grabner; Peter H Rehak; Werner F List; Helfried Metzler
Journal:  Anesthesiology       Date:  2004-09       Impact factor: 7.892

10.  Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497].

Authors:  Des Breen; Andreas Karabinis; Manu Malbrain; Rex Morais; Sven Albrecht; Inge-Lise Jarnvig; Pauline Parkinson; Andrew J T Kirkham
Journal:  Crit Care       Date:  2005-03-15       Impact factor: 9.097

View more
  6 in total

1.  Propofol and remifentanil versus midazolam and fentanyl for sedation during therapeutic hypothermia after cardiac arrest: a randomised trial.

Authors:  Thor W Bjelland; Ola Dale; Kjell Kaisen; Bjørn O Haugen; Stian Lydersen; Kristian Strand; Pål Klepstad
Journal:  Intensive Care Med       Date:  2012-04-12       Impact factor: 17.440

2.  Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version.

Authors:  Jörg Martin; Anja Heymann; Katrin Bäsell; Ralf Baron; Rolf Biniek; Hartmut Bürkle; Peter Dall; Christine Dictus; Verena Eggers; Ingolf Eichler; Lothar Engelmann; Lars Garten; Wolfgang Hartl; Ulrike Haase; Ralf Huth; Paul Kessler; Stefan Kleinschmidt; Wolfgang Koppert; Franz-Josef Kretz; Heinz Laubenthal; Guenter Marggraf; Andreas Meiser; Edmund Neugebauer; Ulrike Neuhaus; Christian Putensen; Michael Quintel; Alexander Reske; Bernard Roth; Jens Scholz; Stefan Schröder; Dierk Schreiter; Jürgen Schüttler; Gerhard Schwarzmann; Robert Stingele; Peter Tonner; Philip Tränkle; Rolf Detlef Treede; Tomislav Trupkovic; Michael Tryba; Frank Wappler; Christian Waydhas; Claudia Spies
Journal:  Ger Med Sci       Date:  2010-02-02

3.  Short-term use of remifentanil during endotracheal extubation for prophylactic analgesia in neurosurgical patients after craniotomy (SURE after Craniotomy Study): a study protocol and statistical analysis plan for a randomised controlled trial.

Authors:  Yuan-Xing Wu; Han Chen; Jian-Xin Zhou
Journal:  BMJ Open       Date:  2014-09-29       Impact factor: 2.692

Review 4.  The place for short-acting opioids: special emphasis on remifentanil.

Authors:  Wolfram Wilhelm; Sascha Kreuer
Journal:  Crit Care       Date:  2008-05-14       Impact factor: 9.097

5.  Analgesia and sedation in the intensive care unit: an overview of the issues.

Authors:  Curtis N Sessler; Wolfram Wilhelm
Journal:  Crit Care       Date:  2008-05-14       Impact factor: 9.097

Review 6.  Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) - short version.

Authors:  Ralf Baron; Andreas Binder; Rolf Biniek; Stephan Braune; Hartmut Buerkle; Peter Dall; Sueha Demirakca; Rahel Eckardt; Verena Eggers; Ingolf Eichler; Ingo Fietze; Stephan Freys; Andreas Fründ; Lars Garten; Bernhard Gohrbandt; Irene Harth; Wolfgang Hartl; Hans-Jürgen Heppner; Johannes Horter; Ralf Huth; Uwe Janssens; Christine Jungk; Kristin Maria Kaeuper; Paul Kessler; Stefan Kleinschmidt; Matthias Kochanek; Matthias Kumpf; Andreas Meiser; Anika Mueller; Maritta Orth; Christian Putensen; Bernd Roth; Michael Schaefer; Rainhild Schaefers; Peter Schellongowski; Monika Schindler; Reinhard Schmitt; Jens Scholz; Stefan Schroeder; Gerhard Schwarzmann; Claudia Spies; Robert Stingele; Peter Tonner; Uwe Trieschmann; Michael Tryba; Frank Wappler; Christian Waydhas; Bjoern Weiss; Guido Weisshaar
Journal:  Ger Med Sci       Date:  2015-11-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.